On behalf of the Organising Committee of the 57th Annual Meeting of the Association for European Paediatric and Congenital Cardiology (AEPC 2024), we would like to thank you for submitting your work as an abstract.

The online submission and evaluation process is administered by Kenes M+, the Meeting Organising Secretariat. 




Please take a moment to read the below guidelines before submitting your abstract:



  • All abstracts must be written in English.
  • All abstracts must be submitted online through the abstract submission system by the deadline given above. Abstracts that are sent via e-mail will not be included in the abstract review process.
  • Please do NOT submit multiple copies of the same abstract.
  • Use acronyms only when necessary and define all abbreviations and concepts in your abstract at first use.
  • The submitting and presenting authors are required to ensure that all co-authors are aware of the content of the abstract before the submission.
  • Always make sure to check the final abstract with the system's preview function before submission, and edit or replace as necessary. It is the authors' responsibility to submit a correct abstract. Any errors in spelling, grammar or scientific fact will be reproduced as typed by the author.
  • Only the accepted abstracts of presenting authors who have completed their registrations and paid their registration fees by the registration deadline for abstract presenters will be included in the Scientific Programme and the AEPC 2024 Supplement issue of the CitY (Cardiology in the Young) Journal.

Accepted abstracts will be published in the "Cardiology in the Young (CitY) Journal". By submitting an abstract, the authors consent in giving AEPC permission to publish their abstracts in the abstract publication, supplement of the official Journal of the AEPC, the Cardiology in the Young (CiTY) Journal.

Since there will be no editing process on the abstracts, the authors are required to avoid any typing errors, misordering of the authors, wrong spelling/writing about the institutions, etc.



STEP 1 - Presentation Options

Topic/Sub-Topic: A main topic that is relevant for your abstract must be selected during Step 1 of the submission process. The Scientific Committee reserves the right to change the topics during the abstract assessment process.

  • The topics for AEPC 2024 are listed on the Meeting website. Please CLICK HERE for reviewing the topics before proceeding with the submission process.
  • Presentation type: Please choose one of the following:

- Oral presentation
- Poster presentation
- Moderated poster presentation
- No preference

The Scientific Committee reserves the right to change the presentation type according to the requirements of the scientific programme.


STEP 2 - Institution Information

The institution(s) of the authors should be indicated fully with the “department” and “institution” names while avoiding any abbreviations such as Dept., Univ., Inst., Hosp., etc.

  • The department and institution details, city and country should be written with lower case while the initials of each word in capitals.
  • Enter each affiliation only once: i.e., if there are 5 authors and 3 of whom are from same affiliation and 2 of whom are from another, you will have 2 institutions, NOT 5. However, if there are 2 or more departments at the same institution represented, they should be entered separately.
  • If any of the authors have more than one affiliation, enter both affiliations in a compounded style as one affiliation: i.e., if there are 5 authors and 2 of whom are from same affiliation (Institute A), 2 of whom are from another (Institute B), and 1 of whom is from both affiliations (Institutes A and B), you will have 3 institutions, NOT 5 or NOT 2. (First institution: Institute A, second one: Institute B and the third one: Institute A & Institute B).
  • Please make sure to include the City and Country information at the end for each institution. For US, please make sure to enter the country information as “United States of America” or “USA” after writing the state name or its abbreviation. For UK, please write the country name as “United Kingdom” or “UK”.


STEP 3 - Author Information

First, middle and last names of all the authors must be fully indicated correctly and in the right order. Please pay attention to match the institutions to the right authors, and make sure that you select the “presenting author” correctly.


STEP 4 - Presenting Author Information

Please enter the presenting author’s contact information correctly. 

  • It’s highly important for you to ensure that the e-mail address of presenting author is entered correctly, as all communication regarding the acceptance, any required adjustments, and scheduling will be sent to the presenting author via e-mail by the Meeting Organising Secretariat.
  • The presenting author will be required to register for the meeting in order to confirm acceptance of the abstract.


STEP 5 - Abstract Title

An abstract must have a short, specific title (containing no abbreviations) that indicates the nature of the investigation.

  • Abstract titles can contain a maximum of 150 characters.
  • Titles should not be written with all capitals.
  • Use only generic drug names. Brand, product or company names must not be used in the abstract title or text. AEPC reserves the right to replace any brand name with a generic name.


STEP 6 - Abstract

Abstract Body: Abstract body should not exceed 350 words. The title of the abstract, authors, institutions and keywords are not included in this limit, and those should not be entered in this section.

  • Abstract body should consist of four sections given below:

Background and Aim: Clearly state the purpose of the abstract.
Methods: Describe your selection of observations or experimental subjects clearly.
Results: Present your results in a logical sequence in text, table and illustrations.
Conclusions: Emphasize new and important aspects of the study (perhaps as a discussion section) and the conclusions that are drawn from them.

  • Standard abbreviations may be used without definition. Non standard abbreviations (kept to a minimum) must be placed in parentheses after the first use of the word or phrase abbreviated.
  • Do not include the names or personal information of any patient participating in a study or trial.
  • Phrases such as “results will be discussed” or “data will be presented” shall not be used.
  • In order to be compatible with universal coding system, only the special characters given on the system should be used. Please note that the abstracts in which other special characters are used may not be displayed correctly in the publications due to the coding systems.
  • Use only generic drug names. Brand, product or company names must not be used in the abstract title or text. AEPC reserves the right to replace any brand name with a generic name.


STEP 7 - Keywords

Keywords should not be included in any of the sections of the abstract body, and written only in the section dedicated for keywords.

  • Minimum 1 keyword is required and maximum 6 keywords can be entered.
  • All keywords should be written in lower case and separated with comma (,). Please do NOT use comma for anything else in the keywords section.


STEP 8 - Additional Files

Images, tables, diagrams and graphs are allowed.


STEP 9 - Preview & Check

The submitting authors are required to preview the abstract at this step and confirm the preview at this step.

  • If you have any comments and/or additional information to be shared with the Scientific Committee, you may enter these details in the comment box.


STEP 10 - Submit to the Committee


Some questions about profession, career level, and possible award applications are being asked at this step. It is required to answer all questions before submitting your abstract. Please select/check your answer and then click on the “Choose” button for each one.

  • If you have not completed all required sections of your abstract, you won’t see the submission button. Only after completing all required fields, the submission button will be enabled for you.


After Submission


When the submission process is finalised, you will see your abstract under the heading "Submitted Abstracts". If your abstract is not seen there, please kindly turn back and check the steps of your submission. Please be aware that the Scientific Committee will not receive "Not-Submitted Abstracts" and these therefore CANNOT be taken into consideration in the abstract evaluation process.

  • Upon submitting of your abstract an e-mail including the "Abstract Number" and "Abstract Title" will be sent to the submitting author. Please make sure to save your username and password for future use. If you cannot remember your credentials, please get in contact with the Meeting Organising Secretariat at (ekose@kenes.com).
  • You can make edits on your abstract before submitting it to the Scientific Committee. After the submission is completed, no edits will be allowed on the system even if there is time until the deadline. In that case, if you have to make some edits on your abstract after submitting but before the submission deadline, please contact with the Meeting Organising Secretariat at (ekose@kenes.com).




All submitted abstracts will be scored and pass through a review process after the submission closes. The notification letters about acceptance of the abstracts will be sent in January 2024.  



The presenting author(s) must be registered for the Annual Meeting latest by January 29, 2024, which is the registration deadline for abstract presenters.

The abstracts of unregistered presenting authors who do not complete registration (including payment) by this deadline will be removed from the final programme and all publications, including the CitY (Cardiology in the Young) Journal.

Thank you for submitting your work for consideration. Please contact us directly at ekose@kenes.com, should you have any specific inquiries.

The extended abstract submission system will close by the deadline Monday, November 27, 2023, by 23:59 Portugal time (GMT +1). Please make sure to check your time difference to determine the submission deadline according to your local time.